Form 4: Accolade Inc. President Acquires Shares Through Employee Stock Purchase Plan

Robert N. Cavanaugh, President of Accolade, Inc., acquired 2,500 shares of common stock through the company's Employee Stock Purchase Plan at a price of $6.53 per share.

Summary

• On May 22, 2024, Robert N. Cavanaugh, President of Accolade, Inc., acquired 2,500 shares of Accolade's common stock.
• The acquisition was made through the company's 2020 Employee Stock Purchase Plan (ESPP).
• The price per share was $6.53, which represents 85% of the closing price of Accolade's common stock on May 20, 2024.
• Following the transaction, Cavanaugh directly owns 175,827 shares of Accolade's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to an employee stock purchase plan, indicating standard corporate practice and employee investment.

Positives

• The acquisition of shares by a company officer can be seen as a positive sign of confidence in the company's future.

Industry Context

Employee stock purchase plans are a common way for companies to incentivize employees and align their interests with those of shareholders. This transaction reflects a standard practice in corporate compensation.

Comparison to Industry Standards

• Employee stock purchase plans are a common benefit offered by many publicly traded companies, including those in the healthcare technology sector like Accolade.
• Typically, these plans allow employees to purchase company stock at a discounted rate, often around 15%, similar to the discount offered in Accolade's ESPP.
• Comparable companies such as Teladoc Health or Livongo (prior to its acquisition by Teladoc) have also utilized similar stock purchase plans to incentivize employee ownership.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the interests of the company president with those of the shareholders.

Key Dates